Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 2,901,012 | reported | 06 Feb 2019 | tx 870+23,346,845−34,712,116 |
| Sarepta Therapeutics, Inc. | 5,518 | reported | 03 Mar 2021 | tx 6+22,644 |
| Kronos Bio, Inc. | 0 | reported | 14 Oct 2020 | tx 7+1,952,364−1,584,176 |
| GEN PROBE INC | 0 | reported | 01 Aug 2012 | tx 29+55,844−55,844 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Mar 2021 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 2,726 | 0.00 USD | |
| 03 Mar 2021 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 5,518 | 0.00 USD | deriv |
| 14 Oct 2020 | CONVERSION | Kronos Bio, Inc. | 914,333 | — | |
| 14 Oct 2020 | PURCHASE | Kronos Bio, Inc. | 75,800 | 19.00 USD | first after silence |
| 14 Oct 2020 | CONVERSION | Kronos Bio, Inc. | 205,260 | 16.15 USD | |
| 14 Oct 2020 | CONVERSION | Kronos Bio, Inc. | 756,971 | — | |
| 14 Oct 2020 | CONVERSION | Kronos Bio, Inc. | — | 0.00 USD | deriv |
| 14 Oct 2020 | CONVERSION | Kronos Bio, Inc. | 866,667 | — | deriv |
| 14 Oct 2020 | CONVERSION | Kronos Bio, Inc. | 717,509 | — | deriv |
| 28 Feb 2020 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 2,075 | 0.00 USD | |
| 28 Feb 2020 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 3,112 | 0.00 USD | |
| 28 Feb 2020 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 5,528 | 0.00 USD | deriv |
| 28 Feb 2020 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 3,685 | 0.00 USD | deriv |
| 06 Feb 2019 | GRANT_AWARD | GILEAD SCIENCES, INC. | 7,745 | 0.00 USD | |
| 06 Feb 2019 | TAX_WITHHOLDING | GILEAD SCIENCES, INC. | 13,787 | 68.75 USD | |
| 06 Feb 2019 | GRANT_AWARD | GILEAD SCIENCES, INC. | 15,505 | 0.00 USD | |
| 03 Dec 2018 | SALE | GILEAD SCIENCES, INC. | 13,958 | 71.95 USD | |
| 03 Dec 2018 | SALE | GILEAD SCIENCES, INC. | 35,842 | 70.90 USD | |
| 03 Dec 2018 | EXERCISE | GILEAD SCIENCES, INC. | 50,000 | 23.60 USD | |
| 29 Nov 2018 | GIFT | GILEAD SCIENCES, INC. | 140,000 | 0.00 USD | |
| 03 Dec 2018 | SALE | GILEAD SCIENCES, INC. | 200 | 72.67 USD | |
| 03 Dec 2018 | EXERCISE | GILEAD SCIENCES, INC. | 50,000 | 0.00 USD | deriv |
| 01 Nov 2018 | EXERCISE | GILEAD SCIENCES, INC. | 50,000 | 23.60 USD | |
| 01 Nov 2018 | SALE | GILEAD SCIENCES, INC. | 13,579 | 70.15 USD | |
| 01 Nov 2018 | SALE | GILEAD SCIENCES, INC. | 28,421 | 69.53 USD |
1 purchase reported after at least 12 months of silence — most recent on 14 Oct 2020.